Cyteir Therapeutics Buy Hold or Sell Recommendation
| CYTDelisted Stock | USD 2.76 0.01 0.36% |
Considering the 90-day investment horizon and complete risk avoidance on your part, our recommendation regarding Cyteir Therapeutics is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Cyteir Therapeutics given historical horizon and risk tolerance towards Cyteir Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Cyteir Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. Note, we conduct extensive research on individual companies such as Cyteir and provide practical buy, sell, or hold advice based on investors' constraints. Cyteir Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
Cyteir |
Execute Cyteir Therapeutics Buy or Sell Advice
The Cyteir recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cyteir Therapeutics. Macroaxis does not own or have any residual interests in Cyteir Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cyteir Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Cyteir Therapeutics Trading Alerts and Improvement Suggestions
| Cyteir Therapeutics is not yet fully synchronised with the market data | |
| Cyteir Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (33.22 M) with loss before taxes, overhead, and interest of (16.59 M). | |
| Cyteir Therapeutics has about 166.4 M in cash with (25.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 77.0% of the company shares are held by institutions such as insurance companies |
Cyteir Therapeutics Returns Distribution Density
The distribution of Cyteir Therapeutics' historical returns is an attempt to chart the uncertainty of Cyteir Therapeutics' future price movements. The chart of the probability distribution of Cyteir Therapeutics daily returns describes the distribution of returns around its average expected value. We use Cyteir Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cyteir Therapeutics returns is essential to provide solid investment advice for Cyteir Therapeutics.
| Mean Return | 0.58 | Value At Risk | -5.26 | Potential Upside | 10.00 | Standard Deviation | 5.51 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cyteir Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Leonard Braden Michael of 113777 shares of Cyteir Therapeutics at 3.01 subject to Rule 16b-3 [view details]
Cyteir Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cyteir . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Cyteir Therapeutics Buy or Sell Advice
When is the right time to buy or sell Cyteir Therapeutics? Buying financial instruments such as Cyteir Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cyteir Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Conservative Funds Thematic Idea Now
Conservative Funds
Funds or Etfs that invest using buy-and-hold investment strategy in companies with consistent growth over many years of operation. The Conservative Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Conservative Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Cyteir Stock
If you are still planning to invest in Cyteir Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cyteir Therapeutics' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |